ATE488529T1 - Zusammensetzungen und verfahren zur behandlung von tumoren - Google Patents
Zusammensetzungen und verfahren zur behandlung von tumorenInfo
- Publication number
- ATE488529T1 ATE488529T1 AT00950879T AT00950879T ATE488529T1 AT E488529 T1 ATE488529 T1 AT E488529T1 AT 00950879 T AT00950879 T AT 00950879T AT 00950879 T AT00950879 T AT 00950879T AT E488529 T1 ATE488529 T1 AT E488529T1
- Authority
- AT
- Austria
- Prior art keywords
- gene
- treatment
- methods
- diagnosis
- compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14621799P | 1999-07-28 | 1999-07-28 | |
PCT/US2000/020731 WO2001009189A2 (en) | 1999-07-28 | 2000-07-27 | Compositions and methods for the treatment of tumors |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE488529T1 true ATE488529T1 (de) | 2010-12-15 |
Family
ID=22516336
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00950879T ATE488529T1 (de) | 1999-07-28 | 2000-07-27 | Zusammensetzungen und verfahren zur behandlung von tumoren |
Country Status (9)
Country | Link |
---|---|
US (2) | US7226596B2 (de) |
EP (1) | EP1204682B1 (de) |
JP (3) | JP2003508028A (de) |
AT (1) | ATE488529T1 (de) |
AU (1) | AU776600B2 (de) |
CA (1) | CA2378182C (de) |
DE (1) | DE60045247D1 (de) |
ES (1) | ES2355055T3 (de) |
WO (1) | WO2001009189A2 (de) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU776600B2 (en) * | 1999-07-28 | 2004-09-16 | Genentech Inc. | Compositions and methods for the treatment of tumors |
WO2003070936A1 (en) | 2002-02-20 | 2003-08-28 | Yamanouchi Pharmaceutical Co., Ltd. | Novel polypeptide |
CN1705753A (zh) * | 2002-09-30 | 2005-12-07 | 肿瘤疗法科学股份有限公司 | 非小细胞肺癌的诊断方法 |
WO2005011619A2 (en) * | 2003-01-31 | 2005-02-10 | Five Prime Therapeutics, Inc. | Lung-expressed polypeptides |
EP1730533A1 (de) * | 2004-03-24 | 2006-12-13 | Oncotherapy Science, Inc. | Adam8 als tumormarker und therapeutisches target von nichtkleinzelligem lungenkrebs |
CN101056890B (zh) * | 2004-11-10 | 2012-05-09 | 诺华疫苗和诊断公司 | 脱酰胺基干扰素-β |
FR2879462B1 (fr) * | 2004-12-21 | 2008-12-26 | Sod Conseils Rech Applic | Utilisation de toxine botulique pour une insensibilisation locale prolongee |
ZA200704934B (en) | 2004-12-22 | 2010-09-29 | Genentech Inc | Methods for producing soluble multi-membrane-spanning proteins |
US20060242012A1 (en) * | 2005-04-22 | 2006-10-26 | Sumit Agarwal | Determining or scoring properties to solicit to join ad network using advertiser or aggregated advertiser interest |
WO2008074840A2 (en) * | 2006-12-19 | 2008-06-26 | Ablynx N.V. | Amino acid sequences directed against a metalloproteinase from the adam family and polypeptides comprising the same for the treatment of adam-related diseases and disorders |
CA3128656A1 (en) | 2007-08-22 | 2009-02-26 | The Regents Of The University Of California | Activatable binding polypeptides and methods of identification and use thereof |
GB2453589A (en) * | 2007-10-12 | 2009-04-15 | King S College London | Protease inhibition |
JP5479355B2 (ja) * | 2007-11-27 | 2014-04-23 | ベリデックス・エルエルシー | 血液中の循環黒色腫細胞の自動計数及び特徴付け |
CA2749339A1 (en) | 2009-01-12 | 2010-07-15 | Cytomx Therapeutics, Llc | Modified antibody compositions, methods of making and using thereof |
CA2753294A1 (en) | 2009-02-23 | 2010-08-26 | Cytomx Therapeutics, Inc. | Proproteins and methods of use thereof |
AU2014265548A1 (en) * | 2013-05-13 | 2016-01-07 | Tufts University | Methods and compositions for prognosis, diagnosis and treatment of ADAM8-expressing cancer |
TW201613622A (en) * | 2014-10-14 | 2016-04-16 | Bionet Corp | Composition for skincare and pharmaceutical composition and preparation method thereof |
TW201613621A (en) * | 2014-10-14 | 2016-04-16 | Bionet Corp | Composition for promoting growth of dermal papilla cells, pharmaceutical composition, and preparation method thereof |
JP2018130113A (ja) * | 2017-02-15 | 2018-08-23 | 国立大学法人 東京大学 | 慢性骨髄性白血病(cml)の検査方法及び検査用キット、チロシンキナーゼ阻害剤(tki)耐性cmlの単離方法、並びにcmlにおけるtki耐性の低減剤及びそのスクリーニング方法 |
EP3976655A4 (de) * | 2019-05-31 | 2023-07-05 | Trustees of Tufts College | Anti-adam8-antikörper und ihre verwendung |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH04187084A (ja) * | 1990-11-22 | 1992-07-03 | Otsuka Pharmaceut Co Ltd | 単球表面に発現する抗原及び該抗原に対するモノクローナル抗体 |
PL179997B1 (pl) * | 1994-01-20 | 2000-11-30 | British Biotech Pharm | Nowe pochodne kwasu hydroksamowego i kwasu karboksylowego PL PL PL PL PL PL |
GB9608130D0 (en) | 1996-04-19 | 1996-06-26 | Univ Sheffield | Adam proteins and uses thereof |
US6132729A (en) * | 1997-01-22 | 2000-10-17 | Board Of Regents, The University Of Texas System | Combined tissue factor and chemotherapeutic methods and compositions for coagulation and tumor treatment |
GB9705521D0 (en) * | 1997-03-18 | 1997-05-07 | Univ Sheffield | The use of mononuclear phagocytes in the vivo imaging of hypoxic/ischaemic tissue |
US5922566A (en) * | 1997-05-13 | 1999-07-13 | Incyte Pharmaceuticals, Inc. | Tumor-associated antigen |
WO1999064626A2 (en) * | 1998-06-06 | 1999-12-16 | Genostic Pharma Limited | Probes used for genetic profiling |
CA2702148C (en) * | 1999-01-06 | 2014-03-04 | Genenews Inc. | Method of profiling gene expression in a human subject having an infectious disease |
US20010034023A1 (en) * | 1999-04-26 | 2001-10-25 | Stanton Vincent P. | Gene sequence variations with utility in determining the treatment of disease, in genes relating to drug processing |
AU776600B2 (en) * | 1999-07-28 | 2004-09-16 | Genentech Inc. | Compositions and methods for the treatment of tumors |
AU2001247219B2 (en) * | 2000-02-25 | 2007-01-04 | Immunex Corporation | Integrin antagonists |
DE60120501T2 (de) * | 2000-03-24 | 2007-01-11 | Micromet Ag | mRNA AMPLIFIZIERUNG |
US6458552B1 (en) * | 2000-06-06 | 2002-10-01 | Ortho-Mcneil Pharmaceutical, Inc. | Metalloprotease peptide substrates and methods |
WO2002029107A2 (en) * | 2000-10-02 | 2002-04-11 | Board Of Regents, The University Of Texas System | Method of detection and interpretation of mutations through expression or function tests of haploid genes |
WO2002048310A2 (en) * | 2000-12-15 | 2002-06-20 | Genetics Institute, Llc | Methods and compositions for diagnosing and treating rheumatoid arthritis |
AU2002305193A1 (en) * | 2001-04-18 | 2002-11-05 | Wyeth | Methods and reagents for regulating bone and cartilage formation |
US20030138792A1 (en) * | 2001-05-31 | 2003-07-24 | Millennium Pharmaceuticals, Inc. | Compositions, kits, and methods for identification, assessment, prevention and therapy of cervical cancer |
AU2002318944A1 (en) * | 2001-08-01 | 2003-02-17 | Coley Pharmaceutical Gmbh | Methods and compositions relating to plasmacytoid dendritic cells |
US20030148334A1 (en) * | 2001-10-12 | 2003-08-07 | Zairen Sun | Differentially-expressed genes and polypeptides in angiogenesis |
CA2477400A1 (en) * | 2002-03-01 | 2003-09-12 | Marc Rothenberg | Treatment for asthma or allergies |
US20040018522A1 (en) * | 2002-05-09 | 2004-01-29 | Brigham And Women's Hospital, Inc. | Identification of dysregulated genes in patients with multiple sclerosis |
US20050003390A1 (en) * | 2002-05-17 | 2005-01-06 | Axenovich Sergey A. | Targets for controlling cellular growth and for diagnostic methods |
JP2004041121A (ja) * | 2002-07-12 | 2004-02-12 | Hitachi Ltd | アレルギー解析方法及びシステム |
US7482117B2 (en) * | 2002-12-20 | 2009-01-27 | Celera Corporation | Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof |
US8088737B2 (en) * | 2003-04-04 | 2012-01-03 | Incyte Corporation | Compositions, methods and kits relating to Her-2 cleavage |
US20050009067A1 (en) * | 2003-05-19 | 2005-01-13 | Craig Logsdon | Expression profile of pancreatic cancer |
WO2005026325A2 (en) * | 2003-09-10 | 2005-03-24 | Surromed, Inc, | Bivalent targeting of cell surfaces |
-
2000
- 2000-07-27 AU AU63913/00A patent/AU776600B2/en not_active Expired
- 2000-07-27 AT AT00950879T patent/ATE488529T1/de active
- 2000-07-27 DE DE60045247T patent/DE60045247D1/de not_active Expired - Lifetime
- 2000-07-27 ES ES00950879T patent/ES2355055T3/es not_active Expired - Lifetime
- 2000-07-27 WO PCT/US2000/020731 patent/WO2001009189A2/en active IP Right Grant
- 2000-07-27 CA CA2378182A patent/CA2378182C/en not_active Expired - Lifetime
- 2000-07-27 JP JP2001513995A patent/JP2003508028A/ja not_active Withdrawn
- 2000-07-27 EP EP00950879A patent/EP1204682B1/de not_active Expired - Lifetime
-
2002
- 2002-08-22 US US10/226,844 patent/US7226596B2/en not_active Expired - Lifetime
-
2007
- 2007-05-25 US US11/754,196 patent/US20080175842A1/en not_active Abandoned
-
2011
- 2011-10-21 JP JP2011231764A patent/JP5897300B2/ja not_active Expired - Lifetime
-
2014
- 2014-03-03 JP JP2014040627A patent/JP2014144959A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2014144959A (ja) | 2014-08-14 |
EP1204682B1 (de) | 2010-11-17 |
JP2012068254A (ja) | 2012-04-05 |
JP5897300B2 (ja) | 2016-03-30 |
US20080175842A1 (en) | 2008-07-24 |
CA2378182C (en) | 2014-09-23 |
WO2001009189A2 (en) | 2001-02-08 |
AU776600B2 (en) | 2004-09-16 |
WO2001009189A3 (en) | 2001-06-14 |
US20030113764A1 (en) | 2003-06-19 |
JP2003508028A (ja) | 2003-03-04 |
DE60045247D1 (de) | 2010-12-30 |
CA2378182A1 (en) | 2001-02-08 |
AU6391300A (en) | 2001-02-19 |
ES2355055T3 (es) | 2011-03-22 |
US7226596B2 (en) | 2007-06-05 |
EP1204682A2 (de) | 2002-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE488529T1 (de) | Zusammensetzungen und verfahren zur behandlung von tumoren | |
WO1999035170A8 (en) | Compositions and methods for the treatment of tumor | |
ATE380195T1 (de) | Zusammensetzungen und verfahren zur behandlung von tumoren | |
WO1999014327A3 (en) | Genes amplified in tumours, antibodies against the proteins coded thereby, and their use in diagnosis and treatment of cancer | |
WO2003032813A3 (en) | Methods for the treatment of carcinoma | |
WO2000053755A3 (en) | Compositions and methods for the treatment of tumor | |
DE60042799D1 (de) | Methoden zur Diagnose von Tumoren | |
WO2004075835A3 (en) | Methods for the treatment of renal cell carcinoma | |
WO2000015666A3 (en) | Compositions and methods for the treatment of tumors | |
ES2329689T3 (es) | Composiciones y procedimientos para el diagnostico de tumores. | |
ATE295963T1 (de) | Zusammensetzungen sowie verfahren zur diagnose und behandlung von tumorerkrankungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1204682 Country of ref document: EP |